Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;36(2):246-253.
doi: 10.1007/s12288-019-01208-4. Epub 2019 Oct 9.

Approach to the Diagnosis of Amyloidosis

Affiliations
Review

Approach to the Diagnosis of Amyloidosis

Richa Juneja et al. Indian J Hematol Blood Transfus. 2020 Apr.

Abstract

Amyloidosis is heterogeneous group of disorder characterized by extracellular deposition of misfolded insoluble proteinaceous material with cross beta pleated sheet structure leading to organ dysfunction. This disease is rare and indeed heterogeneous, as it may be hereditary (familial amyloidosis), secondary to spectrum of inflammatory conditions (AA amyloidosis) or member of plasma cell neoplasm family (AL amyloidosis). AL amyloidosis is the most common type of amyloid, however, is rarely accompanied by multiple myeloma or other lymphoproliferative disorder. This disparity in its origin and presentation needs to be addressed by exhaustive battery of investigation tools, to arrive at right diagnosis with correct typing. This is of utmost importance in guiding the treating physicians to choose appropriate therapeutic options. This review deals with diagnostic approach to amyloidosis and its various subtypes.

Keywords: AA amyloid; AL amyloid; Amyloidosis; Cross beta pleated; Multiple myeloma; Proteinaceous.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a H & E staining showing amorphous, extracellular, eosinophilic material (×100). b Congo red stain showing deep pink to red colored perivascular amyloid (×400). c Amyloid deposits showing apple green birefringence under polarized light (×400)
Fig. 2
Fig. 2
Electron microscopy picture of randomly-oriented, non-branching amyloid fibrils, 7.5–10 nm in diameter, of indeterminate length
Fig. 3
Fig. 3
Diagnostic approach to amyloidosis. *Test for amyloid typing should be chosen depending on availability of tissue and technique

References

    1. Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130(2):88–98. doi: 10.1006/jsbi.2000.4221. - DOI - PubMed
    1. Leung N, Nasr SH, Sethi S. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood. 2012;120(16):3206–3213. doi: 10.1182/blood-2012-03-413682. - DOI - PubMed
    1. Mollee P, Renaut P, Gottlieb D, Goodman H. How to diagnose amyloidosis. Intern Med J. 2014;44(1):7–17. doi: 10.1111/imj.12288. - DOI - PubMed
    1. Tanskanen M. “Amyloid”—Historical aspects. Rijeka: InTech; 2013.
    1. Rosenzweig M, Landau H. Light chain (AL) amyloidosis: update on diagnosis and management. J Hematol OncolJ Hematol Oncol. 2011;18(4):47. doi: 10.1186/1756-8722-4-47. - DOI - PMC - PubMed